FDA Classifies Celexa with Category C
The Food and Drug Administration (FDA) sent an important message to patients, physicians, and the pharmaceutical industry when it labeled Celexa (citalopram) as a Category C prescription drug. The FDA’s risk determination reiterates what scientists and observers have recognized for years: Celexa is dangerous to unborn babies if consumed by women during pregnancy. It’s also important to note that Celexa’s harmful ingredients may also be passed to children through a mother’s breast milk, extending the risk of harm beyond birth.
Celexa is a selective serotonin reuptake inhibitor (SSRI), a class of antidepressant drugs that are dangerous to unborn children. SSRIs like Celexa have been shown in multiple medical studies to cause developmental defects in fetuses, including primary pulmonary hypertension (PPHN), disrupted neurological development, and unusual sleeping patterns. What’s more, the reality is that the medical community remains uncertain about the full risks and harms associated with Celexa.
The attorneys at Fears Nachawati are fighting for victims of Celexa-related injuries and their families. If you or a loved one have suffered as a result Celexa, justice may be within your reach. Talk to us today to learn about the rights of Celexa victims. For a free consultation, call us at 1.866.545.8364 or email firstname.lastname@example.org.